pocketful logo light
pocketful logo light
Kilitch Drugs (India) Ltd logo

Kilitch Drugs (India) Ltd

NSE: KILITCH BSE: 524500

₹183.80

(5.41%)

Mon, 25 May 2026, 00:18 pm

Kilitch Drugs (India) Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters63.7763.7763.7769.2369.23
FII0.0000.000.000
DII0.000.000.000.000.00
Public36.2236.2336.2330.7630.77
Government00000

Kilitch Drugs (India) Ltd Shareholding Pattern

The Kilitch Drugs (India) Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Kilitch Drugs (India) Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Kilitch Drugs (India) Ltd (NSE: KILITCH, BSE: 524500) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Kilitch Drugs (India) Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Kilitch Drugs (India) Ltd Shareholding Pattern (Latest)

The latest Kilitch Drugs (India) Ltd shareholding for Mar 2026 is:

  • Promoters: 63.77%
  • FII: 0.00%
  • DII: 0.00%
  • Public: 36.22%
  • Government: 0%

Promoter holding in Kilitch Drugs (India) Ltd remains stable, reflecting consistent long-term commitment.

Kilitch Drugs (India) Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Kilitch Drugs (India) Ltd.

  • Mar 2026: 63.77%
  • Dec 2025: 63.77%
  • Sept 2025: 63.77%
  • Jun 2025: 69.23%
  • Mar 2025: 69.23%

Promoter stake remains largely stable, showing consistent ownership structure.

Kilitch Drugs (India) Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Kilitch Drugs (India) Ltd.

  • Mar 2026: 0.00%
  • Dec 2025: 0%
  • Sept 2025: 0.00%
  • Jun 2025: 0.00%
  • Mar 2025: 0%

FII holding in Kilitch Drugs (India) Ltd has increased recently, indicating rising foreign investor interest.

Kilitch Drugs (India) Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

  • Mar 2026: 0.00%
  • Dec 2025: 0.00%
  • Sept 2025: 0.00%
  • Jun 2025: 0.00%
  • Mar 2025: 0.00%

DII holdings remain stable, reflecting steady institutional participation.

Kilitch Drugs (India) Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

  • Mar 2026: 36.22%
  • Dec 2025: 36.23%
  • Sept 2025: 36.23%
  • Jun 2025: 30.76%
  • Mar 2025: 30.77%

Public holding remains stable with consistent retail participation.

Kilitch Drugs (India) Ltd Government Holding

Government holding in Kilitch Drugs (India) Ltd currently stands at 0%.

Kilitch Drugs (India) Ltd operates without significant government ownership.

Kilitch Drugs (India) Ltd Shareholding Analysis Summary

The Kilitch Drugs (India) Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Kilitch Drugs (India) Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Kilitch Drugs (India) Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.